Pete Gundermann
Analyst · CJS Securities. Please proceed with your question
Thanks, Debbiee and good morning everybody. Our agenda today is as follows. I'm going to start with a discussion of some of the major issues facing the company, not only in the fourth quarter but looking a little bit backward and looking a little bit forward. There are a number of them, three on the aerospace side and two on the test side. Then I'm going to turn it over to Dave and he's going to walk us through the numbers both on the income statement and the balance sheet and we'll talk a little bit about the future to the extent that we can see it and do the normal question and answer at the end. So major events starting with the aerospace segment and probably the elephant in the room the 737 is a challenge for us. When we last talked, when we released third quarter results in the first week of November, we at that time issued preliminary revenue guidance for 2020 and there were some assumptions stated as part of that revenue guidance, specifically, we assumed that the 737 MAX would see a return service to at or near year end. And at that time we would expect a pretty quick production ramp from 42 airplanes amongst the 47 a month, eventually go into 57 probably sometime out in 2021. Those expectations proved way off based instead of 42 aircraft a month have gone to zero and 800 airplanes plus remain grounded. The 42 airplanes a month going to zero effect fast because we put about just shy of $100,000 a product on each airplane as it's built, that's about $4 million a month in revenue. That's good business for us. It's one of our largest production programs, actually its 42 or 52 units a month. The 800 airplanes grounded essentially cuts the capacity for their airlines around the world and given the lack of capacity that they have, they are reluctant to take airplanes out of service for the passenger amenity, aftermarket products that we offer. So as many of you know – most, you know, most of our sector is not flight critical that we do in the aftermarket. It is an amenity and with a shortage of capacity. We have seen starting late last year a tendency towards the deferral, where programs were in process have been kind of pushing out a little late. This is evidenced in our Q4 bookings, which you see are aerospace bookings were 140 million, that's the last page of our press release, that as well off the pace of recent history, you got to go back a few years for us to be at that level. So we have been asking questions and continue to ask questions of ourselves and of our customers, specifically when will production restart? At this point we, as I said are on a production pause and we have discussions going on with Boeing. There's not a clear resolution for those discussions at this point, so we don't really know. And also when we will return to service occur? That's not so much a Boeing question, that's an FAA question. Once return to service starts, of course we'll have to figure out how those 800 airplanes get implemented by the airlines and when will the airlines, how will they react and what will they kind of respond to normal. So in the meantime, given them the lack of clarity, we have managed down our cost structure as much as we dare in our operations that are specific to the 737. We’re down approximately 50 people, mostly on the direct side in those operations, that's one major issue that we're dealing with on the aerospace side. The second major issue is one that we're in a little bit more control of and that is the three problem kids or problem companies that we've talked about quite a bit over the last year and a half or so. And we actually feel like we're making lots of progress in this area. The fourth quarter operating loss, where the three combined is $5.1 million, that's a lot, but it's down from the average of the first three quarters, which was $9 million, so a brief summary of the three. We've talked in the past about Armstrong, Armstrong in the fourth quarter was within shouting distance of breakeven $200,000 loss down from an average of $800,000 over the first three quarters. We've talked in the past about how we feel Armstrong's basically out of the woods and okay, it's not probably sustainably profitable at this point, but we've integrated it into our CSC operation in Chicago. We've taken three Chicago locations down to two and we expect it to be basically at or near breakeven throughout 2020. We think basically Armstrong's out of the woods. CCC is our second challenge, had a relatively good fourth quarter. The big highlight here is that CCC in the fourth quarter concluded the development process for its Avenir product, which is a state of the art cabin management system for VVIP airplanes that we've been struggling with for about 1.5 year, little bit longer. CCC in the fourth quarter ended up with a $700,000 loss, which again is a lot, but it's way down compared to its average over the first three quarters of $3.3 million loss. So going forward we expect that drop in development expense to basically combined with the revenue increase brings CCC at or near breakeven also for all of 2020. That brings us to AeroSat, I announced in our last call that we were doing a review of the AeroSat business and we were planning to do a restructure. We have implemented that restructuring, it’s a substantial restructuring, basically bringing the focus of the business down from about four business initiatives to one. To give you an indication of the scope, the headcount in the business has gone from about 106 at the beginning of the year to about 44 today and the break even is down from about $40 million level to $10 million today. This was not an inexpensive exercise, the restructuring and impairment charges were quite a bit more than we thought they would be when we started the process ending up at about $29 million for the quarter. AeroSat have evolved a $4 million operating loss in Q4, we expect that to drop to a level that's approximately half of that going forward and getting down towards break even at the end of the year. So when you're looking at the three problem kids and – cumulatively the operating loss, excluding impairments and restructuring charges for 2019 was about $32.7 million. We are quite confident today, that's going to be as we get to the end of 2020 depending on how things evolve with AeroSat at or near breakeven, there could be a minor loss there cumulatively, but in general the numbers won't be anywhere near what they've been in the past. The third issue on our aerospace segment was we took a reserve or a legal process that we've had ongoing in Germany. We talked about this in advance in the fourth – third quarter call also. The charge is more than we expected and we are appealing it. We think the court's decision is deficient and we disagree and the appeal process we expect will last well into 2021. The longer story is that, this is the process that’s been playing out since 2010. The original filings in 2010 were both in the U.S. and Germany, now they had been initiated in France and the UK also. The technology in question frankly is not critical. It is not important. And in fact, we designed it out five years ago in 2013, 2014 when we first figured out that we were going to have an issue here. In the U.S. we over the last couple of years defeated the patent and the case basically ended. In Germany, the patent was downsized or reduced but still stood and the penalty that came down in December was significantly higher than we anticipated. So we took a reserve for 17.9 million additional, bringing the total of Germany to 20.6 million that number is a bit of an estimate. There's a lot of moving parts to the order and some things that we don't know for sure at this point, so it could bounce all around a little bit as we go forward. But until the appeal is heard and resolved, and again, we expect that in 2021, we don't think there's going to be major news in Germany. France and UK are just getting started. The UK first, France will be second and again we think that will probably mostly be 2021 news. We don't expect too many issues to happen here in 2020 on either of these cases. Moving away from our aerospace segment, talking a bit about forces affecting our test business, our test business in 2019 saw a significant year of transition. We in February sold their semiconductor test product line, followers of the company, remember that, I'm sure it was a price of $100 million, the net gain on the sale was about $79 million that shows up in our 2019 income statements as a gain on sale. The revenue from our semiconductor test product line in 2018 was substantial. It was $84 million total for the year, $9.7 million in 2019, so a big drop-off. So year-over-year comparisons or GAAP revenue recognition purposes are quite a bit misleading and the revenue shows a lot stronger in 2018, the gain on sales shows in 2019, this is a big part of the reason why we've gone to an adjusted presentation over the four quarters of 2019. In the second half of 2019, we added a couple of smaller acquisitions to reshape and refocus our test business, Freedom Technologies in July and Diagnosys in October. Freedom is a radio test company, it complements our military focus with the product line geared more at municipal users like police forces or first responders or border patrol. Diagnosys is a complimentary fit in the transit area for train test, that's an area we've gotten into a little bit and we have some pretty strong hopes for this product line for 2020 and onward. Our test business on an adjusted basis backing out the semiconductor sales saw very strong growth in 2019 of 62%; two-thirds organic, one-third acquisition. Margins are not where we expect them in part due to purchase accounting, but we'll talk about the future in a few minutes but kind of a sneak preview on the test side is that we expect 2020 to be another year of pretty strong growth organically in the range of about 20%. We're not issuing guidance today. We rescinded that earlier this month as you know, on a press release we issued on February 3rd. But the test business obviously isn't affected by some of the unknowns in the aerospace world. We're thinking that our test business should be a 20% growth year in 2020. With that I'll pass it over to Dave to talk through the numbers and take it back a little bit later.